Krusch, Andreas: Hochdosischemotherapie bei Hodentumoren: Eine retrospektive Auswertung der Therapieergebnisse von 1989 bis 1995

47

Literatur

(1) Albers P, Dieckmann KP (1998 ): "Hodentumoren: Diagnostik und Therapie des Primärtumors" . Onkologe 4 :487-493

(2) Barnett MJ, Coppin CML, Murray N, Nevill TJ, Reece DE, Klingemann HG, Shepherd JD, Nantel SH, Sutherland HJ, Phillips GL (1993 ): "High-dose chemotherapy and autologous bone marrow transplantation for patients with poor prognosis nonseminomatous germ cell tumors" . Br J Cancer 68 :594-598

(3) Bartlett NL, Freiha FS, Torti FM (1991 "): Serum markers in germ-cell neoplasms. " Hematol Oncol Clin North Am 5 :1173-1187

(4) Beyer J, Bokemeyer C, Schmoll HJ, Siegert W (1994 ): "Treatment intensification in disseminated germ-cell tumors" . World J Uro 12 :207-213

(5) Beyer J, Schwella N, Zingsem J, Strohscheer I, Schwaner I, Oettle H, Serke S, Huhn D, Siegert W (1995 ): "Haematopoetic rescue after high-dose chemotherapy using autologous peripheral-blood progenitor cells or bone marrow: a randomized comparison" . J Clin Oncol 13 :1328-1335

(6) Beyer J, Kramar A, Mandanas R, Linkesch W, Greinix A, Droz JP, Pico JL, Diehl A, Bokemeyer C, Schmoll HJ, Nichols CR, Einhorn LH, Siegert W (1996 ): "High-dose chemotherapy as salvage treatment in germ cell tumors: A multivariate analysis of prognostic variables" . J Clin Oncol 14 :2638-2645

(7) Beyer J, Rick O, Weinknecht S, Kingreen D, Lenz K, Siegert W (1997 ): "Nephrotoxicity after high-dose carboplatin, etoposide and ifosfamide in germ-cell tumors: incidence and implications for hematologic recovery and clinical outcome" . Bone Marrow Transplantation 20 :813-819

(8) Beyer J, Kingreen D, Krause M, Schleicher J, Schwaner I, Schwella N, Huhn D, Siegert W ( 1997 ): "Long term survival of patients with recurrent or refractory germ cell tumors after high dose chemotherapy" . Cancer 79 :161-168

(9) Beyer J, Schmoll HJ ( 1998 ): "Prognostic factors in metastatic germ cell tumors" . Sem Oncol 25 :174-185

(10) Beyer J, Bokemeyer C, Schmoll HJ, Siegert W (1998 ): "Salvagetherapie rezidivierter und refraktärer Hodentumoren" . Onkologe 4 :541-546


48

(11) Bokemeyer C, Schmoll HJ ( 1993 ): "Treatment of advanced germ cell tumors by dose intensified chemotherapy with hematopoetic groth factor or peripheral blood stem cells (PBSC)" . Eur Urol 23 :223-230

(12) Bokemeyer C, Schmoll HJ, Harstrick A, Illiger HJ, Metzner B, Räth U, Hohnloser J, Clemm C, Berdel W, Siegert W, Rüther U, Ostermann H, Kneba M, Hartlapp JH, Schröder M, Poliwoda H (1993 ): "A phase I/II study of a stepwise dose-escalated regimen of cisplatin, etoposide and ifosfamide plus granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients with advanced germ cell tumors" . Eur J Cancer 29 [A ]:2225-2231

(13) Bokemeyer C, Schmoll HJ (1995 ): "Treatment of testicular cancer and the development of secondary malignancies." J Clin Oncol 13 :283-292

(14) Bokemeyer C, Gerl A, Harstrick A, Schmoll HJ (1998 "): Therapie des fortgeschrittenen nichtseminomatösen Keimzelltumors" . Onkologe 4 :532-540

(15) Bosl GJ (1993 ): "Prognostic factors for metastatic testicular germ cell cancer: The Memorial-Sloane-Kettering cancer model" . Eur Urol 23 :182-187

(16) Bosl G, Motzer RJ (1997 ): "Testicular germ-cell cancer" . N Engl J Med 337 :242-253

(17) Broun ER, Nichols CR, Tricot G, Loehrer PJ, Williams SD, Einhorn LH (1991 ): "High-dose carboplatin/VP-16 plus ifosfamide with autologous bone marrow support in the treatment of refractory germ cell tumors" . Bone Marrow Transplant 7 :53-56

(18) Broun ER, Nichols CR, Kneebone P, et al (1992 ): "Long-term outcome of patients with relapsed and refractory germ cell tumors treated with high-dose chemotherapy and autologous bone marrow rescue" . Ann Intern Med, 117 :124-128

(19) Broun ER, Nichols CR, Turns M, et al (1994 ): "Early salvage therapy for germ cell cancer using high dose chemotherapy with autologous bone marrow support" . Cancer 73 :1716-1720

(20) Broun ER, Nichols CR, Gize G, et al (1997 ): "Tandem high-dose chemotherapy with autologous bone marrow transplantation for initial relapse of testicular germ cell cancer" . Cancer, 79 :1605-1610.

(21) Brugger W, Birken R, Bertz H, Hecht T, Pressler K, Frisch J, Schulz G, Mertelsmann R, Kanz L (1993 ): "Peripheral blood progenitor cells mobilized by chemotherapy plus granulocyte-colony stimulating factor accelerate both neutrophil and platelet recovery after high-dose VP16, ifosfamide and cisplatin" . Br J Haematol 84 :402-407


49

(22) Cerny T, Castiglione M, Bruner K, Küpfer A, Martinelli G, Lind M (1990 ): "Ifosfamide by continuous infusion to prevent encephalopathy" . Lancet 335 :175-178

(23) Chevreau C, Droz JP, Pico JL, Biron P, Kerbat P, Cure H, Heron JF, Chevallier B, Fargeot P, Kramar A, Bouzy J (1993 ): "Early intensified chemotherapy with autologous bone marrow transplantation in first line treatment of poor risk non-seminomatous germ cell tumors" . Eur Urol 23 :213-218

(24) Claßen J, Souchon R, Bamberg M (1998): Therapie der frühen Stadien des Seminoms. Onkologe 4:501 -510

(25) Clemm C, Bokemeyer C (1998 ): "Therapie des fortgeschrittenen Seminoms" . Onkologe 4 :524-531

(26) Cockrofft DW, Gault MH (1976 ): "Prediction of creatinine clearance from serum creatinine" . Nephron 16 :31-41

(27) Craig JIO, Turner ML, Parker AC (1992 ): "Peripheral blood stem cell transplantation" . Blood Rev 6 :59-67

(28) Derigs HG, Huber C, Schmoll HJ (1994 ): "Stadienorientierte Therapie bei nichtseminomatösen Hodentumoren" . Dtsch Med Wschr 119 :156-164

(29) Dieckmann KP, Kreuser ED (1991 ): "Aktueller Stand der Chemotherapie von Keimzelltumoren" . Urologe [A] 30 :45-55

(30) Droz JP, Kramar A, Pico JL (1993 ): "Prediction of long-term response after high-dose chemotherapy with autologous bone marrow transplantation in the salvage treatment of non-seminomatous germ cell tumors" . Eur J Cancer 29A : 818-821

(31) Einhorn LH (1990 ): Treatment of testicular cancer: "A new improved model" . J Clin Oncol 11 :1777-1781

(32) Elias AD, Ayash LJ, Wheeler C, Schwartz G, Tepler I, Gronin R, McCauley M, Mazanet R, Schnipper L, Frei III E, Antman KH (1995 ): "Phase I study of high-dose ifosfamide, carboplatin, and etoposide with autologous hematopoetic stem cell support" . Bone Marrow Transplant 15 :373-379

(33) Fields K, Elfenbein GJ, Lazarus H, Cooper BW, Perkins JB, Creger RJ, Ballester OF, Hiemenz JH, Janssen WE, Zorsky PE (1995 ): "Maximum-tolerated doses of ifosfamide, carboplatin, and etoposide given over 6 days followed by autologous stem-cell rescue: toxicity profile" . J Clin Oncol 13 :323-332


50

(34) Fox EP, Loeher PJ (1991 ): "Chemotherapy for advanced testicular cancer" . Hematol Oncol Clin North Am 5 :1173-1187

(35) Gerl A, Clemm C, Schmeller N, et al (1995 ): "Prognosis after salvage treatment for unselected male patients with germ cell tumors" . Br J Cancer, 72 :1026-1032

(36) Gorin NC (1986 ): "Collection, manipulation and freezing of haematopoetic stem cells" . Clin Haematol 15 :19-48

(37) Harstrick A, Schmoll HJ, Wilke H, Köhne-Wömpner CH, Stahl M, Schöber C, Casper J, Buderek L, Schmoll E, Bokemeyer C, Bergmann L, Lammers U, Freund M, Poliwoda H (1991 ): "Cisplatin, etoposide and ifosfamide salvage therapy for refractory or relapsed germ cell carcinoma" . J Clin Oncol 9 :1549-1555

(38) Horwich A, Cullen MH, Stenning SP (1998 ): "Primary chemotherapy after orchidektomy for stage I and II nonseminoma" . Sem Oncol 25 :154-159

(39) International Germ Cell Cancer Collaborative Group (1997 ): "International germ cell consensus classification: a prognostic factor-based staging system for metastatic germ cell cancers" . J Clin Oncol 15 :549-603

(40) Josefsen D, Ous S, Hoie J, et al (1993 ): "Salvage treatment in male patients with germ cell tumors" : Br J Cancer, 67 :568-572

(41) Kaplan EL, Meier P ( 1958 ): "Non-parametric estimation from incomplete observations" . J Am Stat Assoc, 53 :457-481

(42) Karnofsky DA, Abelmann WH, Craver LF, Burchenal JH (1948 ): "The use of the nitrogen mustards in the palliative treatment of carcinoma" . Cancer 1 :634-656

(43) Klumpp TR, Mangan KF, Goldberg SL, Pearlman ES, Macdonald JS (1995 ): "Granulocyte colony-stimulating factor accelerates neutrophil engraftment following peripheral-blood stem-cell transplantation: A prospective, randomized trial" . J Clin Oncol 13 :1323-1327

(44) Kollmannsberger C, Beyer J, Droz JP, Harstrick A, Hartmann JT, Biron P, Fléchon A, Schöffski P, Kuczyk M, Schmoll HJ, Kanz L, Bokemeyer C (1998 "): Secondary leukemia following high cumulativ doses of etoposide in patients treated for advanced germ cell tumors" . J Clin Oncol 16 :3386-3391

(45) Krege S, Weißbach L, Höltl W (1998 ): "Therapie der frühen Stadien des nichtseminomatösen Hodentumors" . Onkologe 4 :511-517


51

(46) Lampe H, Dearnaley D, Price A, et al (1995 ): "High-dose carboplatin and etoposide for salvage chemotherapy of germ cell tumors" . Eur J Cancer, 31[A ]:717-723.

(47) Leeuwen FE van, Stiggelbout AM, van den Belt AW, et al (1993 ): "Second cancer risk following testicular: A follow-up study of 1,909 patients" . J Clin Oncol 11 :415-424

(48) Lewis CR, Fossa SD, Mead G, Ten Bokkel Huinik W, Harding MJ, Mill L, Paul J, Jones WG, Rodenburg CJ, Cantwell B, Keizer HJ, van Oosterom A, Soukop M, Splinter T, Kaye SB (1991 "): BOP/VIP - A new platinum-intensive regimen for poor rognosis germ cell tumors" . Ann Oncol 2 : 203-211

(49) Linkesch W, Krainer M, Wagner A (1992 "): Phase I/II trial of ultrahigh dose carboplatin, etoposide, cyclophosphamide with ABMT in refractory or relapsed nonseminomatous germ cell tumors (GCT)" . Proc Am Soc Clin Oncol 11 :600 (Abstract)

(50) Loehrer PJ, Lauer R, Roth BJ, Williams SD, Kalasinski LA, Einhorn LH (1988 ): "Salvage therapy in recurrent germ cell cancer: Ifosfamide and cisplatin plus either Vinblastine or etoposide" . Ann Intern Med 109 :540-546

(51) Loehrer PJ, Sr, Gonin R, Nichols CR, Weathers T, Einhorn LH (1998 ): Vinblastine plus ifosfamide plus cisplatin as initial salvage therapy in recurrent germ cell tumor. J Clin Oncol 16:2500-2504

(52) Lotz JP, Andre T, Donsimoni R, Firmin C, Bouleuc C, Bonnak H, Merad Z, Esteo A, Gerota J, Israel V (1995 ): "High dose chemotherapy with ifosfamide, carboplatin, and etoposide combined with autologous bone marrow transplantation for the treatment of poor prognosis germ cell tumors and metastatic trophoblastic disease in adults" . Cancer 75 :874-885

(53) Mantel N (1966 ): "Evaluation of survival data and two new rank order statistics arising in ist consideration" . Cancer Treat Rep, 50 :163-170

(54) Margolin K, Doroshow JH, Ahn C, et al (1996 ): "Treatment of germ cell cancer with two cycles of ihgh-dose ifosfamide, carboplatin, and etoposide with autologous stem-cell support" . J Clin Oncol 10 :2631-2637


52

(55) McGaffrey JA, Mazumdar M, Bajorin D, et al (1997 ): "Ifosfamide- and cisplatin-containing chemotherapy as first-line salvage therapy in germ cell tumors: response and survival" . J Clin Oncol, 15 :2559-2563

(56) Miller KD, Loehrer PJ, Gonin R, Einhorn LH (1997 ): "Salvage chemotherapy with vinblastine, ifosfamide, and cisplatin in recurrent seminoma" . J Clin Oncol 15 :1427-1431

(57) Motzer RJ, Gulati SC, Crown JP, et al (1991 ): "High-dose chemotherapy and autologous bone marrow rescue for patients with refractory germ cell tumors" . Cancer 69 :550-556

(58) Motzer RJ, Bajorin DF, Bosl GJ (1992 "): Poor prognosis germ cell tumors: Current progress and future directions" . Sem Oncol 19 :206-214

(59) Motzer RJ, Bosl G ( 1992 ): "High-dose chemotherapy for germ cell tumors: recent advances and future directions" . J Natl Cancer Inst 84 :1703-1709

(60) Motzer RJ, Mazumdar M, Bosl GJ, et al (1996 ): "High-dose carboplatin, etoposide, and cyclophosphamide for patients with refractory germ cell tumors: Treatment results and prognostic factors for survival and toxicity" . J Clin Oncol 14 :1098-1105

(61) Motzer RJ, Mazumdar M, Bajorin DF, et al (1997 ): "High-dose carboplatin , etoposide, and cyclophosphamide with autologous bone marrow transplantation in first-line therapy for patients with poor risk germ cell tumors" . J Clin Oncol 15 :2546-2552

(63) Nichols CR, Tricot G, Williams SD, van Besien K, Loehrer PJ, Roth BJ, Akard L, Hoffman R, Goulet R, Wolff SN, Giannone L, Greer J, Einhorn LH, Jansen J (1989 ): "Dose intensive chemotherapy in refractory germ cell cancer: An Eastern Cooperative Oncology Group protocol" . J Clin Oncol 10 :558-563

(64) Nichols CR, Williams SD, Loehrer PJ, Greco FA, Crawford ED, Weetlaufer J, Miller ME, Bartolucci A, Schacter L, Einhorn LH (1991 ): "Randomized study of cisplatin dose intensity in poor-risk germ cell tumors: A Southeastern Cancer Study Group and Southwest Oncology Group protocol" . J Clin Oncol 9 :1163-1172

(65) Nichols CR, Andersen J, Lazarus HM, et al (1992 ): "High-dose carboplatin and etoposide wtih autologous bone marrow transplantation in refractory germ cell cancer: an Eastern Cooperative Oncology Group protocol" . J Clin Oncol, 10 :558-563.

(66) Nichols CR, Roth BJ, Loehrer PJ, Williams SD, Einhorn LH (1994 ): "Salvage chemotherapy for recurrent germ cell cancer" . Sem Oncol 21(Suppl.12): 102-108


53

(67) Nichols CR, Saxmann S (1998 ): "Primary salvage treatment of recurrent germ cell tumors: Experience at Indiana University" . Semin Oncol 25 :210-214

(68) Osanto S, Bukman A, Hoek F van, et al (1992 "): Long-term effects of chemotherapy in patients with testicular cancer" . J Clin Oncol, 10 :574-579

(69) Rosti G, Albertazzi L, Salvioni R, et al (1992 ): "High-dose chemotherapy supported with autologous bone marrow transplantation (ABMT) in germ cell tumors: A phase two study" . Ann Oncol 3 :809-812

(70) Sachs L (1992 ): Angewandte Statistik. Heidelberg, Springer Verlag

(71) Schmoll HJ (1997 ): "Maligne Keimzelltumoren des Mannes" , in Schmoll HJ, Höffgen K, Possinger K (eds): Kompendium Internistische Onkologie, Teil 2 , Berlin, Springer Verlag, 1997:1225-1279

(72) Siegert W, Beyer J, Strohscheer I, Weisbach V, Heuft HG, Oettle H, Zingsem J, Eckstein R, Schmoll HJ, Huhn D (1992 ): "High-dose carboplatin, etoposide, and ifosfamide followed by autologous stem cell transplantation in poor risk germ cell tumors" . Bone Marrow Transplantation 10 (Suppl 2):26-28

(73) Siegert W, Beyer J, Strohscheer I, Baurmann H, Oettle H, Zingsem J, Zimmermann R, Bokemeyer C, Schmoll HJ, Huhn D (1994 ): "High-dose treatment with carboplatin, etoposide, and ifosfamide followed by autologous stem-cell transplantation in relapsed or refractory germ cell cancer: A phase I/II study. The German Testicular Cancer Cooperative Study Group" . J Clin Oncol 12 :1223-1231

(74) Siegert W, Beyer J (1998 ): "Germ cell tumors: Dose-intensive therapy" . Sem Oncol 25 :215-223

(75) Souchon R, Schmidberger R (1998 "): Diagnostische Maßnahmen zur Definition des klinischen Stadiums" . Onkologe 4 :494-500

(76) Wandl UB, Günzl K, Kath R, Scheulen ME, Hayungs J, Höffken K, Seeber S, Niederle N (1992 ): "Treatment of high-risk, nonseminomatous testicular cancer with cisplatin, ifosfamide and bleomycin: Long term results" . Ann Oncol 3 :123-126

(77) Weißbach L, Harstrick A, Bussar-Maatz U : "Hodentumoren" , in Seeber S, Schütte J (eds): Therapiekonzepte Onkologie, Berlin, Springer Verlag, 1995 :844-869

(78) Weißbach L, Bamberg M, Schmoll HJ (1997 ): "Interdisziplinäre Konsensus-Konferenz zur "Diagnostik und Therapie von Hodentumoren" ". Urologe [A] 36 :362-368


54

(79) Wittekind Ch, Loy V (1998 ): "Pathologie und pathomorphologische Diagnostik von Hodentumoren" . Onkologe 4 :476-486

(80) World Health Organization (1979 ): "WHO handbook for reporting results of cancer treatment" . Geneva: WHO, Offset Publication No.48

Die Ergebnisse der vorliegenden Arbeit sind in folgender Veröffentlichung enthalten:

(81) Rick O, Beyer J, Kingreen D, Schwella N, Krusch A, Schleicher J, Kirsch A, Huhn D, Siegert W (1998 ): "High-dose chemotherapy in germ cell tumors: A large single center experience" . Eur J Cancer 34 :1883-1888


[Titelseite] [Abkürzungsverzeichnis] [1] [2] [3] [4] [5] [Bibliographie] [Danksagung] [Lebenslauf] [Selbständigkeitserklärung]

© Die inhaltliche Zusammenstellung und Aufmachung dieser Publikation sowie die elektronische Verarbeitung sind urheberrechtlich geschützt. Jede Verwertung, die nicht ausdrücklich vom Urheberrechtsgesetz zugelassen ist, bedarf der vorherigen Zustimmung. Das gilt insbesondere für die Vervielfältigung, die Bearbeitung und Einspeicherung und Verarbeitung in elektronische Systeme.

DiML DTD Version 2.0
Zertifizierter Dokumentenserver
der Humboldt-Universität zu Berlin
HTML - Version erstellt am:
Fri Dec 8 14:17:42 2000